Maynard Um
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $120 at Evercore ISI
-
-
-
-
-
-
-
BioMarin reports early VOXZOGO treatment benefits for achondroplasia
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $104 at Canaccord
-
-
-
-
-
-
-
Canaccord Genuity Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy
-
-
-
-
-
-
-
Stifel Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold, 'Stock Might Even Be Too Cheap, But It's Getting Harder to See the Path'
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Tops Q3 EPS by 20c
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
-
402,257 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

